Agios Pharmaceuticals, Inc. - AGIO

SEC FilingsOur AGIO Tweets

About Gravity Analytica

Recent News

  • 02.12.2026 - Agios Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
  • 01.26.2026 - Agios to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call and Webcast on February 12 at 8:00 a.m. ET
  • 01.12.2026 - Agios Outlines 2026 Strategic Priorities and Key Milestones to Accelerate Rare Disease Portfolio Growth
  • 01.05.2026 - Agios to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

Recent Filings

  • 02.12.2026 - 8-K Current report
  • 02.12.2026 - EX-99.1 EX-99.1
  • 02.09.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 02.09.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
  • 01.12.2026 - EX-99.1 EX-99.1
  • 01.12.2026 - 8-K Current report
  • 01.07.2026 - 4 Statement of changes in beneficial ownership of securities
  • 01.05.2026 - 144 Report of proposed sale of securities
  • 01.02.2026 - 4 Statement of changes in beneficial ownership of securities
  • 01.02.2026 - 4 Statement of changes in beneficial ownership of securities